Inventor · disambiguated record
Yik Andy Yeung
Also filed as: YEUNG YIK ANDY
13 granted patents·17 pending applications·88 citations·filing 2004–2025
91Inventor score
Files withPFIZER11ASHER BIOTHERAPEUTICS INC10GENENTECH INC4MASSACHUSETTS INST TECHNOLOGY2LOWMAN HENRY B1
Top patents by PatentIndex Score
30 records- 0196US11814435B2Therapeutic antibodies and their usesPFIZER·Filed 2020·Granted Nov 14, 2023·5 cites·7 claims
- 0296US9969809B2Therapeutic antibodies and their usesPFIZER·Filed 2016·Granted May 15, 2018·44 cites·8 claims
- 0395US11155630B2Therapeutic antibodies and their usesPFIZER·Filed 2020·Granted Oct 26, 2021·3 cites·14 claims
- 0491US11059876B2IL-15 variants and uses thereofPFIZER·Filed 2019·Granted Jul 13, 2021·7 cites·36 claims
- 0591US10793635B2Therapeutic antibodies and their usesPFIZER·Filed 2018·Granted Oct 6, 2020·4 cites·13 claims
- 0689US10040860B2Therapeutic antibodies and their usesPFIZER·Filed 2018·Granted Aug 7, 2018·6 cites·8 claims
- 0787US12122827B2IL-21 polypeptides and targeted constructsASHER BIOTHERAPEUTICS INC·Filed 2023·Granted Oct 22, 2024·1 cites·30 claims
- 0887US11421040B2Antibodies specific for FLT3 and their usesPFIZER·Filed 2018·Granted Aug 23, 2022·5 cites·14 claims
- 0985US12024559B2Fusions with CD8 antigen binding molecules for modulating immune cell functionASHER BIOTHERAPEUTICS INC·Filed 2021·Granted Jul 2, 2024·2 cites·95 claims
- 1085US2024018252A1Therapeutic antibodies and their usesPFIZER·Filed 2023·Application pending·0 cites
- 1181US7413737B2Anti-hydroxylase antibodies and uses thereofMASSACHUSETTS INST TECHNOLOGY·Filed 2004·Granted Aug 19, 2008·11 cites·16 claims
- 1279US2025034242A1Il-21 polypeptides and targeted constructsASHER BIOTHERAPEUTICS INC·Filed 2024·Application pending·0 cites
- 1375US12247072B2IL-21 polypeptides and targeted constructsASHER BIOTHERAPEUTICS INC·Filed 2023·Granted Mar 11, 2025·0 cites·30 claims
- 1469US2025197489A1Il-21 polypeptides and targeted constructsASHER BIOTHERAPEUTICS INC·Filed 2025·Application pending·0 cites
- 1567US2012009182A1Immunoglobulin variants with altered binding to protein aYEUNG YIK ANDY·Filed 2009·Application pending·0 cites
- 1666US2024417470A1Fusions with cd8 antigen binding molecules for modulating immune cell functionASHER BIOTHERAPEUTICS INC·Filed 2024·Application pending·0 cites
- 1765US2010010203A1Anti-hydroxylase antibodies and uses thereofWITTRUP K DANE·Filed 2009·Application pending·0 cites
- 1864US12202910B2Antibodies specific for FLT3 and their usesPFIZER·Filed 2022·Granted Jan 21, 2025·0 cites·8 claims
- 1963US2010098730A1Immunoglobulin variants and uses thereofLOWMAN HENRY B·Filed 2009·Application pending·0 cites
- 2063US2009012267A1Anti-hydroxylase antibodies and uses thereofMASSACHUSETTS INST TECHNOLOGY·Filed 2008·Application pending·0 cites
- 2162US2021002359A1Immunoglobulin variants and uses thereofGENENTECH INC·Filed 2020·Application pending·0 cites
- 2262US2019085094A1Immunoglobulin variants with altered binding to protein aGENENTECH INC·Filed 2018·Application pending·0 cites
- 2362US2021324028A1IL-15 Variants and Uses ThereofPFIZER·Filed 2021·Application pending·0 cites
- 2460US2014294810A1Immunoglobulin variants and uses thereofGENENTECH INC·Filed 2014·Application pending·0 cites
- 2557US2025339519A1Combination of cytokine fusion proteins with cd8 antigen binding moleculesASHER BIOTHERAPEUTICS INC·Filed 2023·Application pending·0 cites
- 2655US2016369007A1Immunoglobulin variants with altered binding to protein aGENENTECH INC·Filed 2016·Application pending·0 cites
- 2752US2024043490A1Targeted cytokine construct for engineered cell therapyASHER BIOTHERAPEUTICS INC·Filed 2021·Application pending·0 cites
- 2848US2024010695A1Fusions of mutant interleukin-10 polypeptides with antigen binding molecules for modulating immune cell functionASHER BIOTHERAPEUTICS INC·Filed 2021·Application pending·0 cites
- 2947US2022251202A1Fusions of mutant interleukin-2 polypeptides with antigen binding molecules for modulating immune cell functionASHER BIOTHERAPEUTICS INC·Filed 2020·Application pending·0 cites
- 3039US12296012B2Chimeric antigen receptors targeting FLT3PFIZER·Filed 2018·Granted May 13, 2025·0 cites·24 claims
Join the waitlist — get patent alerts
Get an alert when Yik Andy Yeung files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →